OpenAlex
PricingAboutJobs
Log inGet started
Work

Examining the safety of PPAR agonists – current trends and future prospects

HTML

Year: 2012
Type: review
Source: Expert Opinion on Drug Safety
DOI: 10.1517/14740338.2013.741585
Authors: Michele Bortolini, Matthew B Wright, Martin Bopst, Bogdana Balas
Institution: F. Hoffmann-La Roche AG
Language: English

Topic: Peroxisome Proliferator-Activated Receptors
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: PPAR agonists, PPARα, PPARγ, fibrates, thiazolidinediones, rosiglitazone, pioglitazone, cardiovascular safety, bladder cancer risk, type 2 diabetes, dyslipidemia, drug safety, cardiometabolic risk factors, insulin resistance, adverse drug reactions
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2089714144
FWCI: 0.717
Cites: 131
Cited by: 83
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security